Iloprost
Showing 1 - 25 of 131
Bronchial Epithelial Dysplasia, COPD, Lung Carcinoma Trial in United States (procedure, drug, other)
Not yet recruiting
- Bronchial Epithelial Dysplasia
- +5 more
- Biospecimen Collection
- +5 more
-
Aurora, Colorado
- +4 more
Aug 4, 2022
COVID-19, ARDS, Human, Hypoxemic Respiratory Failure Trial in Doha (Inhaled ILOPROST)
Completed
- COVID-19
- +2 more
- Inhaled ILOPROST
-
Doha, QatarHamad Medical Corporation
Mar 26, 2022
Respiratory Distress Syndrome, Adult Trial in Tuebingen (Iloprost, control)
Completed
- Respiratory Distress Syndrome, Adult
- Iloprost
- control
-
Tuebingen, GermanyUniversity Hospital Tuebingen
Dec 8, 2021
Proximal Humeral Fracture Trial in Berlin (0.125 ng/kg/min Iloprost, 0.25 ng/kg/min Iloprost, open reduction and internal
Not yet recruiting
- Proximal Humeral Fracture
- 0.125 ng/kg/min Iloprost
- +2 more
-
Berlin, GermanyCenter for Muskuloskeletal Surgery, BIH Center for Regenerative
Mar 9, 2022
Septic Shock Trial in Denmark (Iloprost, Isotonic saline)
Recruiting
- Septic Shock
- Iloprost
- Isotonic saline
-
Copenhagen, Denmark
- +5 more
Nov 26, 2021
Using Breelib Nebulizer, on Clinical Outcomes and Physical
Completed
- Hypertension, Pulmonary
- Iloprost (Ventavis, BAYQ6256)
- Breelib nebulizer
-
Multiple Locations, GermanyMany Locations
May 25, 2021
COVID-19, Respiratory Failure Trial in Denmark (Iloprost, Isotonic saline)
Completed
- COVID-19
- Respiratory Failure
- Iloprost
- Isotonic saline
-
Copenhagen, Denmark
- +4 more
Dec 8, 2021
Mediastinal Mass Trial in Seoul (5ml of inhaled normal saline, 20µg (2ml) of inhaled iloprost (Ventavis®) and 3ml of inhaled
Not yet recruiting
- Mediastinal Mass
- 5ml of inhaled normal saline
- 20μg (2ml) of inhaled iloprost (Ventavis®) and 3ml of inhaled normal saline
-
Seoul, Korea, Republic ofSeverance Hospital, Yonsei University Health System
Jun 9, 2021
Multi Organ Failure Trial in Denmark, Norway (Iloprost, Isotonic saline)
Completed
- Multi Organ Failure
- Iloprost
- Isotonic saline
-
Aalborg, Denmark
- +4 more
Nov 26, 2021
Coronary Artery Occlusive Disease Trial in Seoul (Iloprost, Control (Normal saline))
Unknown status
- Coronary Artery Occlusive Disease
- Iloprost
- Control (Normal saline)
-
Seoul, Korea, Republic ofYonsei Severance Hospital
Nov 4, 2020
Lung Cancer (Including Metastatic Cancer), Pulmonary Infection Trial (normal saline inhalation, iloprost inhalation)
Unknown status
- Lung Cancer (Including Metastatic Cancer)
- Pulmonary Infection
- normal saline inhalation
- iloprost inhalation
- (no location specified)
Oct 4, 2020
Raynaud's Phenomenon Secondary to Systemic Sclerosis Trial in United States (Placebo IV infusion, Iloprost Injection, for
Completed
- Raynaud's Phenomenon Secondary to Systemic Sclerosis
- Placebo IV infusion
- Iloprost Injection, for intravenous use
-
Phoenix, Arizona
- +29 more
Jul 13, 2021
Lung Cancer, Precancerous Condition Trial in United States (iloprost, )
Completed
- Lung Cancer
- Precancerous Condition
- iloprost
- placebo
-
Aurora, Colorado
- +5 more
May 12, 2020
Cardiac Arrest Trial in Copenhagen (Iloprost, Saline, Phillips M1006B, offset by -10mmHg)
Completed
- Cardiac Arrest
- Iloprost
- +3 more
-
Copenhagen, DenmarkDept. of Cardiology, 2143, Rigshospitalet
Mar 9, 2021
Chronic Left Ventricular Failure, Pulmonary Hypertension Trial in Bad Oeynhausen, Heidelberg (Inhaled Iloprost, Placebo)
Withdrawn
- Chronic Left Ventricular Failure
- Pulmonary Hypertension
- Inhaled Iloprost
- Placebo
-
Bad Oeynhausen, Germany
- +1 more
Dec 19, 2019
Raynaud Phenomenon Secondary to Systemic Sclerosis Trial in United States (Placebo IV infusion, Iloprost Injection, for
Completed
- Raynaud Phenomenon Secondary to Systemic Sclerosis
- Placebo IV infusion
- Iloprost Injection, for intravenous use
-
Phoenix, Arizona
- +15 more
Feb 12, 2020
Heart Failure With Normal Ejection Fraction Trial in Taipei (Iloprost, Placebo)
Unknown status
- Heart Failure With Normal Ejection Fraction
- Iloprost
- Placebo
-
Taipei, TaiwanNational Taiwan University Hospital
Aug 11, 2019
Diabetes, Type 2, Insulin Sensitivity/Resistance Trial in Amsterdam (Iloprost infusion)
Completed
- Diabetes Mellitus, Type 2
- Insulin Sensitivity/Resistance
- Iloprost infusion
-
Amsterdam, Noord-Holland, NetherlandsVU University Medical Center
Jul 15, 2019
COPD, Pulmonary Hypertension Trial in Oklahoma City (iloprost Inhalation, iloprost)
Completed
- Chronic Obstructive Pulmonary Disease
- Pulmonary Hypertension
- iloprost Inhalation
- iloprost
-
Oklahoma City, OklahomaUniversity of Oklahoma Health Sciences Center
Jun 5, 2019
Pulmonary Arterial Hypertension Trial in Adelaide (L608 Inhalation Solution, Placebo solution)
Not yet recruiting
- Pulmonary Arterial Hypertension
- L608 Inhalation Solution
- Placebo solution
-
Adelaide, South Australia, AustraliaCMAX Clinical Research Pty Ltd
Jul 12, 2023
Lung Cancer Trial in Seoul (Inhaled iloprost, Distilled water)
Completed
- Lung Cancer
- Inhaled iloprost
- Distilled water
-
Seoul, Korea, Republic ofSeoul St.Mary's Hospital
May 1, 2019
Patients With Pulmonary Hypertension up to 4 Years
Completed
- Pulmonary Hypertension
- Ventavis inhaled (Iloprost, BAYQ6256)
-
Multiple Locations, Turkey(unnamed)
Apr 24, 2019
Pulmonary Hypertension, Chronic Thromboembolic Pulmonary Hypertension Trial in Heidelberg (exercise and respiratory therapy,
Recruiting
- Pulmonary Hypertension
- Chronic Thromboembolic Pulmonary Hypertension
- exercise and respiratory therapy
- sedentary control group
-
Heidelberg, Baden-Wuerttemberg, GermanyThoraxclinic at the University Hospital Heidelberg
Jul 12, 2022
Hypertension, Pulmonary, Cardiac Failure, Pulmonary Vascular Resistance Abnormality Trial in Athens (levosimendan at a dose of 3
Recruiting
- Hypertension, Pulmonary
- +2 more
- levosimendan at a dose of 3 mcg/kg
- +2 more
-
Athens, GreeceOnassis Cardiac Surgery Center
Feb 8, 2022